- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-15-0016536

Alistro Pharmaceuticals Private Limited
About Alistro Pharmaceuticals Private Limited
Data last updated:
Alistro Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 21 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2012PTC145796.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aruna Ashish Chavan and Ashish Balasaheb Chavan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2823/30 Mahalaxmi Nagar Subhash Road, Kolhapur, Maharashtra, India – 416012.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.89 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹3,169 (net margin 0.1%) and EBITDA of ₹28,184 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 259% over three years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Alistro Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-15-0016536). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Alistro Pharmaceuticals
Contact details
Alistro Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra.
- Registered Address2823/30 Mahalaxmi Nagar Subhash Road, Kolhapur, Maharashtra, India – 416012
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alistro Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Alistro Pharmaceuticals Private Limited, buy the company report.
Financials of Alistro Pharmaceuticals Private Limited
FY 2025 filings availableAlistro Pharmaceuticals Private Limited reported revenue of ₹30.89 Lakh (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 259%. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28,184 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,169 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alistro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alistro Pharmaceuticals Private Limited
Alistro Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aruna Ashish Chavan | Director | 21 Dec 2012 | 13 Years 10 Months | Current |
| Ashish Balasaheb Chavan | Additional Director | 16 Mar 2020 | 6 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jan 2022 | 100528303 | Others | ₹5 Lakh | Open |
To see the full charge records of Alistro Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Alistro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alistro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Alistro Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Alistro Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Ashish Balasaheb Chavan was appointed as Additional Director on 16 Mar 2020.
Frequently asked questions
Alistro Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 21 December 2012 (14+ years old) and is registered under CIN U24232PN2012PTC145796.
Alistro Pharmaceuticals has 2 current directors:
- Aruna Ashish Chavan - Director
- Ashish Balasaheb Chavan - Additional Director
The latest financial statements of Alistro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Alistro Pharmaceuticals is U24232PN2012PTC145796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alistro Pharmaceuticals was incorporated on 21 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
Ashish Balasaheb Chavan was appointed as Additional Director on 16 Mar 2020. Vyankoba Narsingrao Vadone ceased to be Director on 16 Mar 2020. Ashish Balasaheb Chavan ceased to be Director on 16 Sep 2013. Alistro Pharmaceuticals has 4 board changes on record in total.
Yes, Alistro Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-15-0016536).
The registered office of Alistro Pharmaceuticals is at 282330 Mahalaxmi Nagar Subhash Road, Kolhapur, Maharashtra, India – 416012.
Alistro Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Alistro Pharmaceuticals has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.

